Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year in a randomized trial; results that suggest self-monitoring should not be routine in these patients, according to a new study.
Click here to read the article in JAMA Internal Medicine.The Diabetes Channel
June 20, 2017 • Diabetes, Endocrinology, Family Medicine, Internal Medicine, Men's Health, The JAMA Report, Women’s Health